Noopept 150mg Spray (1.5mg per spray)

TheraTide USA

$19.99
Availability:
In Stock
Adding to cart… The item has been added

Product Overview

 

Compound: Noopept (N‑phenylacetyl‑L‑prolylglycine ethyl ester) nasal spray

Format: 150 mg total, ~1.5 mg per metered spray

For research use only—NOT for human or veterinary use.

Each batch is tested by third‑party labs for ≥98% purity. COAs are available on request via providers@theratideusa.com.

Noopept is a synthetic nootropic that acts as a prodrug to the endogenous dipeptide cyclo‑prolyl‑glycine, enhancing AMPA & acetylcholine signaling, and boosting BDNF/NGF expression :contentReference[oaicite:1]{index=1}.

  • Neuroprotection: Protects against amyloid-β, oxidative stress, calcium overload, and glutamate toxicity in cellular & animal models :contentReference[oaicite:2]{index=2}.
  • Synaptic plasticity: Enhances NMDA receptor activity and supports synapse formation through increased BDNF/NGF :contentReference[oaicite:3]{index=3}.
  • Pain & inflammation: Reduces microglial activity, spinal cell apoptosis, and inflammatory pain in rodent models :contentReference[oaicite:4]{index=4}.
  • Rapid nasal action: Intranasal delivery enables fast absorption, improved brain targeting, and potential benefits for memory, stress, and focus :contentReference[oaicite:5]{index=5}.

Most data are preclinical; limited human studies indicate cognitive improvements but require more research :contentReference[oaicite:6]{index=6}.

How does nasal noopept compare to oral?
Nasal delivery bypasses digestion for faster brain absorption, potentially offering more immediate cognitive benefits :contentReference[oaicite:7]{index=7}.

What benefits are expected?
Promotes memory, focus, neuroprotection, mood support, and reduced pain in preclinical models :contentReference[oaicite:8]{index=8}.

What dosage is typical?
Most studies use low microgram-to-milligram doses; spray is metered at ~1.5 mg per pump.

Side effects?
Generally well tolerated; mild headache or dizziness have been reported in some cases :contentReference[oaicite:9]{index=9}.

Are there human studies?
Open-label trials showed improved cognition in mild cognitive disorders at ~10 mg/day for 56 days :contentReference[oaicite:10]{index=10}.

For laboratory research only—not for human or veterinary use, nor as a dietary supplement.

Safety: Use under lab conditions; handle responsibly and store securely.

FDA Notice: Statements not evaluated by FDA. Not intended to diagnose, treat, cure, or prevent any disease.

All products offered by TheraTide USA are strictly intended for research and development purposes only.

None of the statements on this website have been evaluated by the U.S. Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease.

TheraTide USA is a research chemical supplier. We are not a compounding pharmacy or a chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act.